Home > Publications database > Möglichkeiten und Grenzen der Nutzung kleiner Zyklotrone bei der Produktion medizinisch relevanter Radionuklide > print

001     893193
005     20210623133503.0
024 7 _ |a 10.1055/a-1380-7815
|2 doi
024 7 _ |a 0723-7065
|2 ISSN
024 7 _ |a 1439-5800
|2 ISSN
024 7 _ |a 2128/27955
|2 Handle
037 _ _ |a FZJ-2021-02617
082 _ _ |a 610
100 1 _ |a Neumaier, Bernd
|0 P:(DE-Juel1)166419
|b 0
|e Corresponding author
|u fzj
245 _ _ |a Möglichkeiten und Grenzen der Nutzung kleiner Zyklotrone bei der Produktion medizinisch relevanter Radionuklide
260 _ _ |a Stuttgart
|c 2021
|b Thieme
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1623823629_15032
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Radionuclides for in vivo imaging studies as well as for internal radiotherapy are produced using both nuclear reactors and cyclotrons. In this contribution we discuss the possibilities of production of different types of radionuclides using a small medical cyclotron (Ep = 18 MeV; Ed = 9 MeV). Besides routine production of short-lived “standard” positron emitters 11C, 15O and 18F, several “non-standard” positron emitters like 64Cu, 86Y, 89Zr etc. could also be produced in quantities sufficient for extended positron emission tomography. It is, however, necessary to develop a suitable target system for irradiation of enriched material. In principle, it is then also possible to produce in small amounts a few SPECT radionuclides (67Ga, 111In, 123I) as well as therapy-related radionuclides (67Cu, 103Pd, 186Re)
536 _ _ |a 525 - Decoding Brain Organization and Dysfunction (POF4-525)
|0 G:(DE-HGF)POF4-525
|c POF4-525
|x 0
|f POF IV
588 _ _ |a Dataset connected to CrossRef, Journals: juser.fz-juelich.de
700 1 _ |a Spahn, Ingo
|0 P:(DE-Juel1)131849
|b 1
|u fzj
700 1 _ |a Qaim, Syed M.
|0 P:(DE-Juel1)131840
|b 2
|u fzj
773 _ _ |a 10.1055/a-1380-7815
|g Vol. 44, no. 02, p. 120 - 126
|0 PERI:(DE-600)2092413-6
|n 02
|p 120 - 126
|t Der @Nuklearmediziner
|v 44
|y 2021
|x 0723-7065
856 4 _ |u https://juser.fz-juelich.de/record/893193/files/Autorenversion.docx
|y Published on 2021-06-10. Available in OpenAccess from 2022-06-10.
909 C O |o oai:juser.fz-juelich.de:893193
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 0
|6 P:(DE-Juel1)166419
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 1
|6 P:(DE-Juel1)131849
910 1 _ |a Forschungszentrum Jülich
|0 I:(DE-588b)5008462-8
|k FZJ
|b 2
|6 P:(DE-Juel1)131840
913 0 _ |a DE-HGF
|b Key Technologies
|l Decoding the Human Brain
|1 G:(DE-HGF)POF3-570
|0 G:(DE-HGF)POF3-573
|3 G:(DE-HGF)POF3
|2 G:(DE-HGF)POF3-500
|4 G:(DE-HGF)POF
|v Neuroimaging
|x 0
913 1 _ |a DE-HGF
|b Key Technologies
|l Natural, Artificial and Cognitive Information Processing
|1 G:(DE-HGF)POF4-520
|0 G:(DE-HGF)POF4-525
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-500
|4 G:(DE-HGF)POF
|v Decoding Brain Organization and Dysfunction
|x 0
914 1 _ |y 2021
915 _ _ |a Embargoed OpenAccess
|0 StatID:(DE-HGF)0530
|2 StatID
915 _ _ |a No Peer Review
|0 StatID:(DE-HGF)0020
|2 StatID
920 _ _ |l yes
920 1 _ |0 I:(DE-Juel1)INM-5-20090406
|k INM-5
|l Nuklearchemie
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a UNRESTRICTED
980 _ _ |a I:(DE-Juel1)INM-5-20090406
980 1 _ |a FullTexts

LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21